free prostate specific antigen Search Results


notch1 polyclonal antibody  (Cell Signaling Technology Inc)
93
Cell Signaling Technology Inc notch1 polyclonal antibody
Notch1 Polyclonal Antibody, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/free+prostate+specific+antigen/Prostate+Specific+Membrane+Antigen+XP+Rabbit+mAb/pmc11382803-165-100-111
Average 93 stars, based on 1 article reviews
notch1 polyclonal antibody - by Bioz Stars, 2026-09
93/100 stars
  Buy from Supplier
anti psma  (Cell Signaling Technology Inc)
94
Cell Signaling Technology Inc anti psma
Anti Psma, supplied by Cell Signaling Technology Inc, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/free+prostate+specific+antigen/Prostate+Specific+Membrane+Antigen+Rabbit+mAb/pmc10970688-129-23-26
Average 94 stars, based on 1 article reviews
anti psma - by Bioz Stars, 2026-09
94/100 stars
  Buy from Supplier
rabbit anti prostate specific antigen psa  (Proteintech)
93
Proteintech rabbit anti prostate specific antigen psa
Rabbit Anti Prostate Specific Antigen Psa, supplied by Proteintech, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/free+prostate+specific+antigen/KLK3%2FPSA+Antibody/pmc11591464-78-129-134
Average 93 stars, based on 1 article reviews
rabbit anti prostate specific antigen psa - by Bioz Stars, 2026-09
93/100 stars
  Buy from Supplier
e el m0961  (Elabscience Biotechnology)
94
Elabscience Biotechnology e el m0961
E El M0961, supplied by Elabscience Biotechnology, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/free+prostate+specific+antigen/Mouse+PSA+(Prostate+Specific+Antigen)+ELISA+Kit/pm39796507-87-1-2
Average 94 stars, based on 1 article reviews
e el m0961 - by Bioz Stars, 2026-09
94/100 stars
  Buy from Supplier
prostatespecific antigen psa  (Elabscience Biotechnology)
94
Elabscience Biotechnology prostatespecific antigen psa
Prostatespecific Antigen Psa, supplied by Elabscience Biotechnology, used in various techniques. Bioz Stars score: 94/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/free+prostate+specific+antigen/Rat+PSA+(Prostate+Specific+Antigen)+ELISA+Kit/pm40582100-63-4-11
Average 94 stars, based on 1 article reviews
prostatespecific antigen psa - by Bioz Stars, 2026-09
94/100 stars
  Buy from Supplier
psa  (OriGene)
90
OriGene psa
Fig. 2 Time course of the fluorescent intensity of the microfluidic immunoassay. The 0 min of amplification time in the horizontal axis is defined as the time from which both F-SA and b-anti-SA start flowing into the microchannel. <t>PSA</t> was diluted <t>with</t> <t>PBS</t> containing 1% BSA (a-1 and a-2) or human female serum (b-1 and b-2). Each data point is the average of four measurements obtained by four independent experiments. Additionally, fluorescence was obtained from LFDA (a-1 and b-1) or from no amplification (a-2 and b-2). The concentrations of PSA: blank (▼), 4.0 ng/mL (△), 100 ng/mL (■), 1.0 μg/mL (×), and 10 μg/mL (◣).
Psa, supplied by OriGene, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/free+prostate+specific+antigen/Prostate+Specific+Antigen+(KLK3)+(total+PSA+epitope+4)+Mouse+Monoclonal+Antibody/pm21415503-51-8-9
Average 90 stars, based on 1 article reviews
psa - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier
monoclonal psa antibody  (Bio-Rad)
90
Bio-Rad monoclonal psa antibody
Fig. 2 Time course of the fluorescent intensity of the microfluidic immunoassay. The 0 min of amplification time in the horizontal axis is defined as the time from which both F-SA and b-anti-SA start flowing into the microchannel. <t>PSA</t> was diluted <t>with</t> <t>PBS</t> containing 1% BSA (a-1 and a-2) or human female serum (b-1 and b-2). Each data point is the average of four measurements obtained by four independent experiments. Additionally, fluorescence was obtained from LFDA (a-1 and b-1) or from no amplification (a-2 and b-2). The concentrations of PSA: blank (▼), 4.0 ng/mL (△), 100 ng/mL (■), 1.0 μg/mL (×), and 10 μg/mL (◣).
Monoclonal Psa Antibody, supplied by Bio-Rad, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/free+prostate+specific+antigen/Mouse+anti+Human+Prostate+Specific+Antigen/10__1155_slash_2011_slash_983752-43-6-24
Average 90 stars, based on 1 article reviews
monoclonal psa antibody - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier
antigen elisa kit  (ALPCO)
93
ALPCO antigen elisa kit
In vivo effects of AMPK activation. Average tumor volume of LNCaP xenografts during 14-day treatment with MT 63–78 (30 mg/kg, i.p.). Experiments were performed twice for a total number of 17 mice under treatment and 15 controls. Results are expressed as n fold the mean initial volume (equal to 1) ± s.e.m. (* P = 0.049, end of treatment, Unpaired t -test). Representative image of treated and control mice (with similar pre-treatment tumor volume) and their excised tumors at sacrifice. Correspondent western blot analysis of key proteins belonging to lipogenic and mTORC1 pathways is shown. Densitometric analysis of phosphorylated ACC and Raptor in tumor homogenates of all treated mice ( n = 16) and controls ( n = 15). One treated mouse was not included in the analysis because frozen material was not available. Highlighted (black circle) are the two tumors with the highest ACC phosphorylation and volume reduction. Results are expressed in arbitrary units, after normalization to Vinculin. Unpaired t -test and Wilcoxon Mann–Whitney t -test were performed. Significant P values are reported on the graphs. Average tumor volume of LNCaP xenografts during 21-day treatment with MT 63–78 (60 mg/kg, i.p., five mice) and vehicle (six mice). Results are expressed as n fold the mean initial volume (equal to 1) ± s.e.m. (** P = 0.004, end of treatment, Wilcoxon Mann–Whitney test). One mouse from treated group was removed from the study since biochemical analysis showed that the drug for unknown reasons did not penentrate in the tumor. Densitometric analysis of phosphorylated ACC and Raptor performed as in C. Unpaired t -tests were performed. Significant P values are reported on the graphs. <t>Serum</t> <t>PSA</t> levels measured at the end of the 21-day treatment with MT 63–78 (60 mg/kg, i.p.) in five treated and five control mice. Results are expressed as mean ± s.e.m. <t>ELISA</t> was performed twice (each sample in duplicate) with similar results. A representative experiment is shown. Serum from one control mouse was not available. Unpaired t -test was performed ( P = 0.27). PIN incidence in FASN-Tg α2 +/+ ( n = 34), FASN-Tg/AMPK α2 +/− ( n = 28), FASN-Tg/AMPK α2 −/− ( n = 7) age-matched mice. Logistic regression P = 0.077, with post hoc calculated power of 0.44. Source data are available for this figure.
Antigen Elisa Kit, supplied by ALPCO, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/free+prostate+specific+antigen/Total+Prostate-Specific+Antigen+ELISA/pmc03992078-218-8-11
Average 93 stars, based on 1 article reviews
antigen elisa kit - by Bioz Stars, 2026-09
93/100 stars
  Buy from Supplier
antigen  (Lee Biosolutions)
91
Lee Biosolutions antigen
In vivo effects of AMPK activation. Average tumor volume of LNCaP xenografts during 14-day treatment with MT 63–78 (30 mg/kg, i.p.). Experiments were performed twice for a total number of 17 mice under treatment and 15 controls. Results are expressed as n fold the mean initial volume (equal to 1) ± s.e.m. (* P = 0.049, end of treatment, Unpaired t -test). Representative image of treated and control mice (with similar pre-treatment tumor volume) and their excised tumors at sacrifice. Correspondent western blot analysis of key proteins belonging to lipogenic and mTORC1 pathways is shown. Densitometric analysis of phosphorylated ACC and Raptor in tumor homogenates of all treated mice ( n = 16) and controls ( n = 15). One treated mouse was not included in the analysis because frozen material was not available. Highlighted (black circle) are the two tumors with the highest ACC phosphorylation and volume reduction. Results are expressed in arbitrary units, after normalization to Vinculin. Unpaired t -test and Wilcoxon Mann–Whitney t -test were performed. Significant P values are reported on the graphs. Average tumor volume of LNCaP xenografts during 21-day treatment with MT 63–78 (60 mg/kg, i.p., five mice) and vehicle (six mice). Results are expressed as n fold the mean initial volume (equal to 1) ± s.e.m. (** P = 0.004, end of treatment, Wilcoxon Mann–Whitney test). One mouse from treated group was removed from the study since biochemical analysis showed that the drug for unknown reasons did not penentrate in the tumor. Densitometric analysis of phosphorylated ACC and Raptor performed as in C. Unpaired t -tests were performed. Significant P values are reported on the graphs. <t>Serum</t> <t>PSA</t> levels measured at the end of the 21-day treatment with MT 63–78 (60 mg/kg, i.p.) in five treated and five control mice. Results are expressed as mean ± s.e.m. <t>ELISA</t> was performed twice (each sample in duplicate) with similar results. A representative experiment is shown. Serum from one control mouse was not available. Unpaired t -test was performed ( P = 0.27). PIN incidence in FASN-Tg α2 +/+ ( n = 34), FASN-Tg/AMPK α2 +/− ( n = 28), FASN-Tg/AMPK α2 −/− ( n = 7) age-matched mice. Logistic regression P = 0.077, with post hoc calculated power of 0.44. Source data are available for this figure.
Antigen, supplied by Lee Biosolutions, used in various techniques. Bioz Stars score: 91/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/free+prostate+specific+antigen/Prostate+Specific+Antigen+(PSA)%2C+Human+Semen/pm37521792-52-1-15
Average 91 stars, based on 1 article reviews
antigen - by Bioz Stars, 2026-09
91/100 stars
  Buy from Supplier
human prostate stem cell antigen psca elisa kit  (Cusabio)
90
Cusabio human prostate stem cell antigen psca elisa kit
SNPs located in exons.
Human Prostate Stem Cell Antigen Psca Elisa Kit, supplied by Cusabio, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/free+prostate+specific+antigen/Human+prostate+specific+antigen%2CPSA+ELISA+Kit/pmc05958807-155-0-14
Average 90 stars, based on 1 article reviews
human prostate stem cell antigen psca elisa kit - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier
templates  (OriGene)
90
OriGene templates
SNPs located in exons.
Templates, supplied by OriGene, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/free+prostate+specific+antigen/Prostate+Specific+Antigen+(KLK3)+(NM_001648)+Human+Untagged+Clone/pmc04619118-276-61-59
Average 90 stars, based on 1 article reviews
templates - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier
human prostate  (OriGene)
90
OriGene human prostate
SNPs located in exons.
Human Prostate, supplied by OriGene, used in various techniques. Bioz Stars score: 90/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/free+prostate+specific+antigen/Human+Prostate+Specific+Antigen+(PSA)+ELISA+kit/pmc08619582-58-13-20
Average 90 stars, based on 1 article reviews
human prostate - by Bioz Stars, 2026-09
90/100 stars
  Buy from Supplier

Image Search Results


Fig. 2 Time course of the fluorescent intensity of the microfluidic immunoassay. The 0 min of amplification time in the horizontal axis is defined as the time from which both F-SA and b-anti-SA start flowing into the microchannel. PSA was diluted with PBS containing 1% BSA (a-1 and a-2) or human female serum (b-1 and b-2). Each data point is the average of four measurements obtained by four independent experiments. Additionally, fluorescence was obtained from LFDA (a-1 and b-1) or from no amplification (a-2 and b-2). The concentrations of PSA: blank (▼), 4.0 ng/mL (△), 100 ng/mL (■), 1.0 μg/mL (×), and 10 μg/mL (◣).

Journal: Analytical sciences : the international journal of the Japan Society for Analytical Chemistry

Article Title: Power-free microchip immunoassay of PSA in human serum for point-of-care testing.

doi: 10.2116/analsci.27.237

Figure Lengend Snippet: Fig. 2 Time course of the fluorescent intensity of the microfluidic immunoassay. The 0 min of amplification time in the horizontal axis is defined as the time from which both F-SA and b-anti-SA start flowing into the microchannel. PSA was diluted with PBS containing 1% BSA (a-1 and a-2) or human female serum (b-1 and b-2). Each data point is the average of four measurements obtained by four independent experiments. Additionally, fluorescence was obtained from LFDA (a-1 and b-1) or from no amplification (a-2 and b-2). The concentrations of PSA: blank (▼), 4.0 ng/mL (△), 100 ng/mL (■), 1.0 μg/mL (×), and 10 μg/mL (◣).

Article Snippet: Sample solutions of PSA were created by diluting PSA (Acris Antibody, Herford, Germany) either in PBS (pH 7.5, Cambrex Biosciences, Walkersville, MD) or in human female serum (Scipac, Kent, UK) to the desired concentrations.

Techniques: Amplification, Fluorescence

Fig. 3 Calibration curve of PSA diluted in PBS (a-1 and a-2) or human female serum (b-1 and b-2). The error bars represent one standard deviation of four independent experiments. (a-1 or b-1) The curves were obtained from LFDA and the amplification time was 7.0 min. Insets magnify the graphs of the low concentration range. (a-2 and b-2) Calibration curve of PSA without amplification as control experiments. The time of detection was 4.0 min after the start of flow of F-SA.

Journal: Analytical sciences : the international journal of the Japan Society for Analytical Chemistry

Article Title: Power-free microchip immunoassay of PSA in human serum for point-of-care testing.

doi: 10.2116/analsci.27.237

Figure Lengend Snippet: Fig. 3 Calibration curve of PSA diluted in PBS (a-1 and a-2) or human female serum (b-1 and b-2). The error bars represent one standard deviation of four independent experiments. (a-1 or b-1) The curves were obtained from LFDA and the amplification time was 7.0 min. Insets magnify the graphs of the low concentration range. (a-2 and b-2) Calibration curve of PSA without amplification as control experiments. The time of detection was 4.0 min after the start of flow of F-SA.

Article Snippet: Sample solutions of PSA were created by diluting PSA (Acris Antibody, Herford, Germany) either in PBS (pH 7.5, Cambrex Biosciences, Walkersville, MD) or in human female serum (Scipac, Kent, UK) to the desired concentrations.

Techniques: Standard Deviation, Amplification, Concentration Assay, Control

In vivo effects of AMPK activation. Average tumor volume of LNCaP xenografts during 14-day treatment with MT 63–78 (30 mg/kg, i.p.). Experiments were performed twice for a total number of 17 mice under treatment and 15 controls. Results are expressed as n fold the mean initial volume (equal to 1) ± s.e.m. (* P = 0.049, end of treatment, Unpaired t -test). Representative image of treated and control mice (with similar pre-treatment tumor volume) and their excised tumors at sacrifice. Correspondent western blot analysis of key proteins belonging to lipogenic and mTORC1 pathways is shown. Densitometric analysis of phosphorylated ACC and Raptor in tumor homogenates of all treated mice ( n = 16) and controls ( n = 15). One treated mouse was not included in the analysis because frozen material was not available. Highlighted (black circle) are the two tumors with the highest ACC phosphorylation and volume reduction. Results are expressed in arbitrary units, after normalization to Vinculin. Unpaired t -test and Wilcoxon Mann–Whitney t -test were performed. Significant P values are reported on the graphs. Average tumor volume of LNCaP xenografts during 21-day treatment with MT 63–78 (60 mg/kg, i.p., five mice) and vehicle (six mice). Results are expressed as n fold the mean initial volume (equal to 1) ± s.e.m. (** P = 0.004, end of treatment, Wilcoxon Mann–Whitney test). One mouse from treated group was removed from the study since biochemical analysis showed that the drug for unknown reasons did not penentrate in the tumor. Densitometric analysis of phosphorylated ACC and Raptor performed as in C. Unpaired t -tests were performed. Significant P values are reported on the graphs. Serum PSA levels measured at the end of the 21-day treatment with MT 63–78 (60 mg/kg, i.p.) in five treated and five control mice. Results are expressed as mean ± s.e.m. ELISA was performed twice (each sample in duplicate) with similar results. A representative experiment is shown. Serum from one control mouse was not available. Unpaired t -test was performed ( P = 0.27). PIN incidence in FASN-Tg α2 +/+ ( n = 34), FASN-Tg/AMPK α2 +/− ( n = 28), FASN-Tg/AMPK α2 −/− ( n = 7) age-matched mice. Logistic regression P = 0.077, with post hoc calculated power of 0.44. Source data are available for this figure.

Journal: EMBO Molecular Medicine

Article Title: A novel direct activator of AMPK inhibits prostate cancer growth by blocking lipogenesis

doi: 10.1002/emmm.201302734

Figure Lengend Snippet: In vivo effects of AMPK activation. Average tumor volume of LNCaP xenografts during 14-day treatment with MT 63–78 (30 mg/kg, i.p.). Experiments were performed twice for a total number of 17 mice under treatment and 15 controls. Results are expressed as n fold the mean initial volume (equal to 1) ± s.e.m. (* P = 0.049, end of treatment, Unpaired t -test). Representative image of treated and control mice (with similar pre-treatment tumor volume) and their excised tumors at sacrifice. Correspondent western blot analysis of key proteins belonging to lipogenic and mTORC1 pathways is shown. Densitometric analysis of phosphorylated ACC and Raptor in tumor homogenates of all treated mice ( n = 16) and controls ( n = 15). One treated mouse was not included in the analysis because frozen material was not available. Highlighted (black circle) are the two tumors with the highest ACC phosphorylation and volume reduction. Results are expressed in arbitrary units, after normalization to Vinculin. Unpaired t -test and Wilcoxon Mann–Whitney t -test were performed. Significant P values are reported on the graphs. Average tumor volume of LNCaP xenografts during 21-day treatment with MT 63–78 (60 mg/kg, i.p., five mice) and vehicle (six mice). Results are expressed as n fold the mean initial volume (equal to 1) ± s.e.m. (** P = 0.004, end of treatment, Wilcoxon Mann–Whitney test). One mouse from treated group was removed from the study since biochemical analysis showed that the drug for unknown reasons did not penentrate in the tumor. Densitometric analysis of phosphorylated ACC and Raptor performed as in C. Unpaired t -tests were performed. Significant P values are reported on the graphs. Serum PSA levels measured at the end of the 21-day treatment with MT 63–78 (60 mg/kg, i.p.) in five treated and five control mice. Results are expressed as mean ± s.e.m. ELISA was performed twice (each sample in duplicate) with similar results. A representative experiment is shown. Serum from one control mouse was not available. Unpaired t -test was performed ( P = 0.27). PIN incidence in FASN-Tg α2 +/+ ( n = 34), FASN-Tg/AMPK α2 +/− ( n = 28), FASN-Tg/AMPK α2 −/− ( n = 7) age-matched mice. Logistic regression P = 0.077, with post hoc calculated power of 0.44. Source data are available for this figure.

Article Snippet: Serum PSA levels were measured using Total Prostate-Specific Antigen ELISA kit (Alpco).

Techniques: In Vivo, Activation Assay, Control, Western Blot, Phospho-proteomics, MANN-WHITNEY, Enzyme-linked Immunosorbent Assay

SNPs located in exons.

Journal: Oncology Letters

Article Title: Correlation between prostate stem cell antigen gene expression and oral squamous cell carcinoma

doi: 10.3892/ol.2018.8468

Figure Lengend Snippet: SNPs located in exons.

Article Snippet: Human Prostate Stem Cell Antigen (PSCA) ELISA kit (cat no. CSB-EL018840HU) was purchased from CUSABIO BIOTECH (Stratech, Scientific, Ltd., UK).

Techniques:

Allele distribution of the 12 selected SNPs.

Journal: Oncology Letters

Article Title: Correlation between prostate stem cell antigen gene expression and oral squamous cell carcinoma

doi: 10.3892/ol.2018.8468

Figure Lengend Snippet: Allele distribution of the 12 selected SNPs.

Article Snippet: Human Prostate Stem Cell Antigen (PSCA) ELISA kit (cat no. CSB-EL018840HU) was purchased from CUSABIO BIOTECH (Stratech, Scientific, Ltd., UK).

Techniques: Control

The rs2294008 polymorphism in PSCA . OSCC, oral squamous cell carcinoma; PSCA, prostate stem cell antigen.

Journal: Oncology Letters

Article Title: Correlation between prostate stem cell antigen gene expression and oral squamous cell carcinoma

doi: 10.3892/ol.2018.8468

Figure Lengend Snippet: The rs2294008 polymorphism in PSCA . OSCC, oral squamous cell carcinoma; PSCA, prostate stem cell antigen.

Article Snippet: Human Prostate Stem Cell Antigen (PSCA) ELISA kit (cat no. CSB-EL018840HU) was purchased from CUSABIO BIOTECH (Stratech, Scientific, Ltd., UK).

Techniques:

Genotype distribution of the 8 SNPs.

Journal: Oncology Letters

Article Title: Correlation between prostate stem cell antigen gene expression and oral squamous cell carcinoma

doi: 10.3892/ol.2018.8468

Figure Lengend Snippet: Genotype distribution of the 8 SNPs.

Article Snippet: Human Prostate Stem Cell Antigen (PSCA) ELISA kit (cat no. CSB-EL018840HU) was purchased from CUSABIO BIOTECH (Stratech, Scientific, Ltd., UK).

Techniques: Control

PSCA expression pattern in eight cancer and two normal cell lines. OSCC, oral squamous cell carcinoma; PSCA, prostate stem cell antigen.

Journal: Oncology Letters

Article Title: Correlation between prostate stem cell antigen gene expression and oral squamous cell carcinoma

doi: 10.3892/ol.2018.8468

Figure Lengend Snippet: PSCA expression pattern in eight cancer and two normal cell lines. OSCC, oral squamous cell carcinoma; PSCA, prostate stem cell antigen.

Article Snippet: Human Prostate Stem Cell Antigen (PSCA) ELISA kit (cat no. CSB-EL018840HU) was purchased from CUSABIO BIOTECH (Stratech, Scientific, Ltd., UK).

Techniques: Expressing

PSCA expression in OSCC and normal serum.

Journal: Oncology Letters

Article Title: Correlation between prostate stem cell antigen gene expression and oral squamous cell carcinoma

doi: 10.3892/ol.2018.8468

Figure Lengend Snippet: PSCA expression in OSCC and normal serum.

Article Snippet: Human Prostate Stem Cell Antigen (PSCA) ELISA kit (cat no. CSB-EL018840HU) was purchased from CUSABIO BIOTECH (Stratech, Scientific, Ltd., UK).

Techniques: Expressing

PSCA protein expression in OSCC and normal tissues.

Journal: Oncology Letters

Article Title: Correlation between prostate stem cell antigen gene expression and oral squamous cell carcinoma

doi: 10.3892/ol.2018.8468

Figure Lengend Snippet: PSCA protein expression in OSCC and normal tissues.

Article Snippet: Human Prostate Stem Cell Antigen (PSCA) ELISA kit (cat no. CSB-EL018840HU) was purchased from CUSABIO BIOTECH (Stratech, Scientific, Ltd., UK).

Techniques: Expressing, Enzyme-linked Immunosorbent Assay

PSCA expression in OSCC tissues. (A and B) Representative images indicating PSCA expression in tissues from patients with OSCC and PSCA-positive serum (IRS=6; A, 100×; B, 200×). (C and D) PSCA expression in tissues from patients with OSCC and PSCA-negative serum (IRS=2; C, ×100; D, ×200). OSCC, oral squamous cell carcinoma; PSCA, prostate stem cell antigen.

Journal: Oncology Letters

Article Title: Correlation between prostate stem cell antigen gene expression and oral squamous cell carcinoma

doi: 10.3892/ol.2018.8468

Figure Lengend Snippet: PSCA expression in OSCC tissues. (A and B) Representative images indicating PSCA expression in tissues from patients with OSCC and PSCA-positive serum (IRS=6; A, 100×; B, 200×). (C and D) PSCA expression in tissues from patients with OSCC and PSCA-negative serum (IRS=2; C, ×100; D, ×200). OSCC, oral squamous cell carcinoma; PSCA, prostate stem cell antigen.

Article Snippet: Human Prostate Stem Cell Antigen (PSCA) ELISA kit (cat no. CSB-EL018840HU) was purchased from CUSABIO BIOTECH (Stratech, Scientific, Ltd., UK).

Techniques: Expressing

PSCA expression in normal epithelium. Representative images from normal tissue with an IRS=0 (A, ×100; B, ×200). OSCC, oral squamous cell carcinoma; PSCA, prostate stem cell antigen.

Journal: Oncology Letters

Article Title: Correlation between prostate stem cell antigen gene expression and oral squamous cell carcinoma

doi: 10.3892/ol.2018.8468

Figure Lengend Snippet: PSCA expression in normal epithelium. Representative images from normal tissue with an IRS=0 (A, ×100; B, ×200). OSCC, oral squamous cell carcinoma; PSCA, prostate stem cell antigen.

Article Snippet: Human Prostate Stem Cell Antigen (PSCA) ELISA kit (cat no. CSB-EL018840HU) was purchased from CUSABIO BIOTECH (Stratech, Scientific, Ltd., UK).

Techniques: Expressing

PSCA expression in OSCC epithelium with different genotypes. (A and B) Representative images indicating PSCA expression in tissues from OSCC patients presenting the CC genotype (A, ×100; B, ×200). (C and D) Representative images indicating PSCA expression in OSCC patients presenting the CT genotype (C, ×100; D, ×200). Representative images indicating PSCA expression in tissues from OSCC patients presenting the TT genotype (E, ×100; F, ×200). OSCC, oral squamous cell carcinoma; PSCA, prostate stem cell antigen.

Journal: Oncology Letters

Article Title: Correlation between prostate stem cell antigen gene expression and oral squamous cell carcinoma

doi: 10.3892/ol.2018.8468

Figure Lengend Snippet: PSCA expression in OSCC epithelium with different genotypes. (A and B) Representative images indicating PSCA expression in tissues from OSCC patients presenting the CC genotype (A, ×100; B, ×200). (C and D) Representative images indicating PSCA expression in OSCC patients presenting the CT genotype (C, ×100; D, ×200). Representative images indicating PSCA expression in tissues from OSCC patients presenting the TT genotype (E, ×100; F, ×200). OSCC, oral squamous cell carcinoma; PSCA, prostate stem cell antigen.

Article Snippet: Human Prostate Stem Cell Antigen (PSCA) ELISA kit (cat no. CSB-EL018840HU) was purchased from CUSABIO BIOTECH (Stratech, Scientific, Ltd., UK).

Techniques: Expressing